Dr. John K. Chan, MD
Gynecologic Oncology (Gynecologic Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of California, Geffen School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 202
Licensed in California since 1997, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of California, Geffen School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gynecologic Oncology Physician primary
CA license A61661 (first issued 1997; current) -
Obstetrics & Gynecology Physician
CA license A61661 (first issued 1997; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- California PAcific Medical Center- Van Ness Campus San Francisco, CA
- Peninsula Medical Center Burlingame, CA
- Alta Bates Summit Medical Center - Alta Bates Camp Berkeley, CA
- California PAcific Medical Ctr-Davies Campus Hosp San Francisco, CA
- California PAcific Medical Center - Mission Bernal San Francisco, CA
Medical groups
- Sutter Bay Medical Foundation (3,829 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 202
- Services billed
- 606
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 131 | 55 |
| Established patient office or other outpatient visit, 30-39 minutes | 113 | 84 |
| Established patient office or other outpatient visit, 20-29 minutes | 100 | 77 |
| New patient office or other outpatient visit, 60-74 minutes | 65 | 65 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 14 | 14 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acetaminophen-Codeine (acetaminophen with codeine) Other prescribers in San Francisco, CA | 48 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in San Francisco, CA | 12 |
| Letrozole Other prescribers in San Francisco, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 200 payments worth $338,199 in total to this clinician.
| GlaxoSmithKline, LLC. | $137,769 |
|---|---|
| Eisai Inc. | $81,693 |
| AstraZeneca Pharmaceuticals LP | $63,020 |
| AbbVie Inc. | $21,958 |
| Genmab U.S., Inc. | $19,577 |
| Pfizer Inc. | $12,139 |
| Eisai Co., LTD. | $1,226 |
| Corcept Therapeutics | $440 |
| Compensation for services other than consulting (speaking, faculty) | $218,118 |
|---|---|
| Speaking at a medical education program | $69,363 |
| Travel and Lodging | $23,242 |
| Consulting Fee | $21,808 |
| Food and Beverage | $5,578 |
| Education | $90.20 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| AstraZeneca Pharmaceuticals LP Dec 2, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| AstraZeneca Pharmaceuticals LP Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| AstraZeneca Pharmaceuticals LP Jan 7, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| Eisai Inc. Jun 2, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Mar 14, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Aug 27, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. May 8, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Jun 26, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Pfizer Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) TIVDAK · ONCOLOGY | $5,750 |
All 143 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genmab U.S., Inc. Dec 30, 2025 | Travel and Lodging Tivdak · Oncology · travel to Las Vegas, NV · in-kind | $7.95 |
| Corcept Therapeutics Dec 12, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind Company’s descriptionLODGING | $161 |
| Genmab U.S., Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty) Tivdak · Oncology | $5,750 |
| AstraZeneca Pharmaceuticals LP Dec 8, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $4,920 |
| AstraZeneca Pharmaceuticals LP Dec 2, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| GlaxoSmithKline, LLC. Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| GlaxoSmithKline, LLC. Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $2,850 |
| GlaxoSmithKline, LLC. Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| Genmab U.S., Inc. Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) Tivdak · Oncology | $5,750 |
| Eisai Inc. Nov 20, 2025 | Travel and Lodging Lenvima · Oncology · travel to Modesto, CA | $591 |
| AstraZeneca Pharmaceuticals LP Nov 20, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to Riverside, CA · in-kind Company’s descriptionSpeaker Expenses | $110 |
| Eisai Inc. Nov 19, 2025 | Travel and Lodging Lenvima · Oncology · travel to Modesto, CA | $1,027 |
| Genmab U.S., Inc. Nov 19, 2025 | Travel and Lodging Tivdak · Oncology · travel to Tucson, AZ · in-kind | $15.91 |
| Eisai Inc. Nov 18, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,715 |
| Eisai Inc. Nov 18, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,263 |
| GlaxoSmithKline, LLC. Nov 12, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Jackson Hole, WY · in-kind | $565 |
| GlaxoSmithKline, LLC. Nov 12, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Jackson Hole, WY · in-kind | $240 |
| GlaxoSmithKline, LLC. Nov 11, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Ogden, UT · in-kind | $885 |
| GlaxoSmithKline, LLC. Nov 11, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Ogden, UT · in-kind | $562 |
| GlaxoSmithKline, LLC. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $475 |
| Genmab U.S., Inc. Oct 27, 2025 | Travel and Lodging Tivdak · Oncology · travel to Henderson, NV · in-kind | $7.96 |
| Genmab U.S., Inc. Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) Tivdak · Oncology | $4,625 |
| Genmab U.S., Inc. Oct 14, 2025 | Travel and Lodging Tivdak · Oncology · travel to Tucson, AZ · in-kind | $272 |
| GlaxoSmithKline, LLC. Oct 10, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $950 |
| AstraZeneca Pharmaceuticals LP Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $2,460 |
| GlaxoSmithKline, LLC. Oct 3, 2025 | Consulting Fee JEMPERLI · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Oct 3, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to SAN FRANCISCO, CA | $19.77 |
| AstraZeneca Pharmaceuticals LP Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| GlaxoSmithKline, LLC. Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,800 |
| AbbVie Inc. Sep 22, 2025 | Consulting Fee ELAHERE · ONCOLOGY | $3,488 |
| AbbVie Inc. Sep 19, 2025 | Consulting Fee | $3,100 |
| AstraZeneca Pharmaceuticals LP Sep 19, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $1,640 |
| Genmab U.S., Inc. Sep 18, 2025 | Travel and Lodging Tivdak · Oncology · travel to Henderson, NV · in-kind | $325 |
| Genmab U.S., Inc. Sep 18, 2025 | Travel and Lodging Tivdak · Oncology · travel to Las Vegas, NV · in-kind | $166 |
| GlaxoSmithKline, LLC. Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| GlaxoSmithKline, LLC. Aug 28, 2025 | Consulting Fee JEMPERLI · ONCOLOGY | $2,000 |
| AstraZeneca Pharmaceuticals LP Aug 28, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to TOMBALL, TX · in-kind Company’s descriptionSpeaker Expenses | $605 |
| Eisai Inc. Aug 27, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Aug 27, 2025 | Speaking at a medical education program Lenvima · Oncology | $4,890 |
| Eisai Inc. Aug 27, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. Aug 27, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. Aug 23, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $201 |
| Eisai Inc. Aug 21, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $626 |
| AstraZeneca Pharmaceuticals LP Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $1,640 |
| GlaxoSmithKline, LLC. Aug 13, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Reno, NV · in-kind | $412 |
| GlaxoSmithKline, LLC. Aug 13, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Reno, NV · in-kind | $306 |
| GlaxoSmithKline, LLC. Aug 8, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| AbbVie Inc. Aug 7, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $3,875 |
| Genmab U.S., Inc. Jul 25, 2025 | Consulting Fee Epkinly · Oncology · in-kind | $2,400 |
| AstraZeneca Pharmaceuticals LP Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $1,640 |
| AstraZeneca Pharmaceuticals LP Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $1,640 |
| GlaxoSmithKline, LLC. Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Jul 14, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $2,400 |
| GlaxoSmithKline, LLC. Jul 8, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to San Diego, CA · in-kind | $375 |
| AbbVie Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $1,550 |
| Eisai Inc. Jun 30, 2025 | Consulting Fee Lenvima · Oncology | $408 |
| Eisai Inc. Jun 26, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Jun 26, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| GlaxoSmithKline, LLC. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $4,800 |
| AstraZeneca Pharmaceuticals LP Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $4,920 |
| GlaxoSmithKline, LLC. Jun 17, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Tacoma, WA · in-kind | $240 |
| GlaxoSmithKline, LLC. Jun 17, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Seattle, WA · in-kind | $227 |
| Pfizer Inc. Jun 13, 2025 | Consulting Fee TIVDAK · ONCOLOGY | $720 |
| GlaxoSmithKline, LLC. Jun 6, 2025 | Education in-kind | $64.50 |
| AbbVie Inc. Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $3,875 |
| Eisai Inc. Jun 2, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Jun 2, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. May 29, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $1,117 |
| GlaxoSmithKline, LLC. May 29, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Denver, CO · in-kind | $520 |
| AstraZeneca Pharmaceuticals LP May 28, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to HOUSTON, TX · in-kind Company’s descriptionSpeaker Expenses | $411 |
| GlaxoSmithKline, LLC. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $2,400 |
| Pfizer Inc. May 20, 2025 | Travel and Lodging TIVDAK · ONCOLOGY · travel to Pasadena, CA · in-kind | $274 |
| Pfizer Inc. May 20, 2025 | Travel and Lodging TIVDAK · ONCOLOGY · travel to Costa Mesa, CA · in-kind | $274 |
| Pfizer Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) TIVDAK · ONCOLOGY | $5,750 |
| Pfizer Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) TIVDAK · ONCOLOGY | $4,625 |
| GlaxoSmithKline, LLC. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,800 |
| Eisai Inc. May 9, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. May 9, 2025 | Speaking at a medical education program Lenvima · Oncology | $815 |
| Eisai Inc. May 8, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. May 8, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. May 8, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $218 |
| Eisai Inc. May 8, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $157 |
| AstraZeneca Pharmaceuticals LP May 6, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $4,920 |
| Pfizer Inc. May 6, 2025 | Travel and Lodging TIVDAK · ONCOLOGY · travel to Costa Mesa, CA · in-kind | $89.92 |
| Pfizer Inc. May 6, 2025 | Travel and Lodging TIVDAK · ONCOLOGY · travel to Pasadena, CA · in-kind | $89.91 |
| Pfizer Inc. May 6, 2025 | Travel and Lodging TIVDAK · ONCOLOGY · travel to Costa Mesa, CA · in-kind | $33.09 |
| Pfizer Inc. May 6, 2025 | Travel and Lodging TIVDAK · ONCOLOGY · travel to Pasadena, CA · in-kind | $33.09 |
| GlaxoSmithKline, LLC. May 5, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. May 5, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. May 5, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $2,400 |
| Merck Sharp & Dohme LLC May 2, 2025 | Education KEYTRUDA · ONCOLOGY · in-kind | $25.70 |
| Eisai Inc. Apr 30, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $291 |
| GlaxoSmithKline, LLC. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $3,200 |
| Eisai Inc. Apr 28, 2025 | Travel and Lodging Lenvima · Oncology · travel to San Francisco, CA | $630 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Duarte, CA · in-kind | $367 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Duarte, CA · in-kind | $293 |
| GlaxoSmithKline, LLC. Apr 16, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to San Diego, CA · in-kind | $203 |
| GlaxoSmithKline, LLC. Apr 14, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Los Angeles, CA · in-kind | $247 |
| GlaxoSmithKline, LLC. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Chico, CA · in-kind | $1,985 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Sacramento, CA · in-kind | $522 |
| GlaxoSmithKline, LLC. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Apr 3, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Eureka, CA · in-kind | $2,314 |
| GlaxoSmithKline, LLC. Apr 3, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Eureka, CA · in-kind | $167 |
| GlaxoSmithKline, LLC. Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Mar 21, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Arcadia, CA · in-kind | $418 |
| Eisai Inc. Mar 20, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. Mar 20, 2025 | Speaking at a medical education program Lenvima · Oncology | $815 |
| Eisai Inc. Mar 14, 2025 | Speaking at a medical education program Lenvima · Oncology | $6,520 |
| Eisai Inc. Mar 14, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| AstraZeneca Pharmaceuticals LP Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| AstraZeneca Pharmaceuticals LP Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $3,280 |
| AstraZeneca Pharmaceuticals LP Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $2,460 |
| AstraZeneca Pharmaceuticals LP Mar 6, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to Portland, OR · in-kind Company’s descriptionSpeaker Expenses | $262 |
| Eisai Inc. Mar 5, 2025 | Travel and Lodging Lenvima · Oncology · travel to Seattle, WA | $577 |
| GlaxoSmithKline, LLC. Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Mar 4, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Costa Mesa, CA · in-kind | $383 |
| GlaxoSmithKline, LLC. Mar 4, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Costa Mesa, CA · in-kind | $105 |
| AbbVie Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $2,175 |
| Eisai Inc. Feb 26, 2025 | Consulting Fee Lenvima · Oncology | $2,445 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $2,400 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Fullerton, CA · in-kind | $203 |
| AbbVie Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $3,625 |
| Eisai Inc. Jan 30, 2025 | Travel and Lodging Lenvima · Oncology · travel to Stockton, CA | $1,259 |
| Eisai Inc. Jan 30, 2025 | Travel and Lodging Lenvima · Oncology · travel to Stockton, CA | $441 |
| Eisai Inc. Jan 29, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,445 |
| Eisai Inc. Jan 29, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,445 |
| Eisai Inc. Jan 29, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Inc. Jan 29, 2025 | Speaking at a medical education program Lenvima · Oncology | $2,038 |
| Eisai Co., LTD. Jan 24, 2025 | Consulting Fee Lenvima · Oncology | $1,226 |
| Eisai Inc. Jan 24, 2025 | Consulting Fee Lenvima · Oncology | $1,223 |
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,350 |
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,350 |
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,350 |
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $4,350 |
| GlaxoSmithKline, LLC. Jan 21, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Iowa City, IA · in-kind | $1,086 |
| GlaxoSmithKline, LLC. Jan 21, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Iowa City, IA · in-kind | $327 |
| GlaxoSmithKline, LLC. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $363 |
| AstraZeneca Pharmaceuticals LP Jan 7, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $6,560 |
| AstraZeneca Pharmaceuticals LP Jan 7, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $4,920 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $72,090 in research payments for these studies, mostly to the institutions running them.
- Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
AbbVie Inc. · Active, not recruiting · NCT05456685 - A phase 1B/2 multicohort umbrella study to evaluate the safety and eff
GlaxoSmithKline, LLC. - A phase 3, randomized, double-blind, placebo-controlled, multicenter s
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.